Serum PSA and percent free PSA value changes after antibiotic treatment: A diagnostic method in prostate cancer suspects with asymptomatic prostatitis

Urologia Internationalis

Volumn 80, Issue 2, 2008, Pages 186-192

  Kobayashi, Minoru ^a,b   Nukui, Akinori ^a   Morita, Tatsuo ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Sano Kosei General Hospital   (Japan)

Author keywords

Antibiotics, prostate specific antigen; Percent free prostate specific antigen; Prostate cancer; Prostate specific antigen; Subclinical prostatitis

Indexed keywords

ANTIBIOTIC AGENT; PROSTATE SPECIFIC ANTIGEN;

AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEASIBILITY STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATITIS; TREATMENT RESPONSE; URINE;

AGED; ANTI-BACTERIAL AGENTS; HUMANS; MALE; OFLOXACIN; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS;

EID: 41149114495     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112612     Document Type: Article

References (38)

1. Remzi M, Djavan B, Wammack R, Momeni M, Seitz C, Erne B, Dobrovits M, Alavi S, Marberger M: Can total and transition zone volume of the prostate determine whether to perform a repeat biopsy? Urology 2003;61:161-166.
2. Armitage TG, Cooper EH, Newling DW, Robinson MR, Appleyard I: The value of the measurement of serum prostate specific antigen in patients with benign prostatic hyperplasia and untreated prostate cancer. Br J Urol 1988;62:584-589.
3. Benson MC, Whang IS, Pantuck A, Ring K, Kaplan SA, Olsson CA, Cooner WH: Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992;147(3 Pt 2):815-816.
4. Neal DE Jr, Clejan S, Sarma D, Moon TD: Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992;20:105-111.
5. Reissigl A, Klocker H, Pointner J, Fink K, Horninger W, Ennemoser O, Strasser H, Colleselli K, Höltl L, Bartsch G: Usefulness of the ratio free/total prostate-specific antigen in addition to total PSA levels in prostate cancer screening. Urology 1996;48(6A suppl):62-66.
6. Recker F, Kwiatkowski MK, Piironen T, Petterson K, Goepel M, Scholl R: Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels. Br J Urol 1998;81:532-538.
7. Woodrum DL, Brawer MK, Partin AW, Catalona WJ, Southwick PC: Interpretation of free prostate specific antigen clinical research studies for the detection of prostate cancer. J Urol 1998;159:5-12.
8. Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, Freschi M, Rigatti P: Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol 1999;36:621-630.
9. Minardi D, Galosi AB, Recchioni A, Giammarco L, Polito M, Muzzonigro G: Diagnostic accuracy of percent free prostate-specific antigen in prostatic pathology and its usefulness in monitoring prostatic cancer patients. Urol Int 2001;67:272-282.
10. Stancik I, Lüftenegger W, Klimpfinger M, Müller MM, Hoeltl W: Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004;46:760-764.
11. Rowe EW, Laniado ME, Walker MM, Anup P: Incidental acute prostatic inflammation is associated with a lower percentage of free prostate-specific antigen than other benign conditions of the prostate: a prospective screening study. BJU Int 2006;97:1039-1042.
12. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y: Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994;25:91-96.
13. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL: Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995;154(2 Pt 1):407-413.
14. Tchetgen MB, Oesterling JE: The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin North Am 1997;24:283-291.
15. Irani J, Levillain P, Goujon JM, Bon D, Doré B, Aubert J: Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997;157:1301-1303.
16. Schatteman PH, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E: Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis: correlation with total serum PSA and PSA density. Eur Urol 2000;37:404-412.
17. Nickel JC, Downey J, Young I, Boag S: Asymptomatic inflammation and/or infection in benign prostatic hyperplasia. BJU Int 1999;84:976-981.
18. Morote J, Lopez M, Encabo G, de Torres IM: Effect of inflammation and benign prostatic enlargement on total and percent free serum prostatic specific antigen. Eur Urol 2000;37:537-540.
19. Okada K, Kojima M, Naya Y, Kamoi K, Yokoyama K, Takamatsu T, Miki T: Correlation of histological inflammation in needle biopsy specimens with serum prostate-specific antigen levels in men with negative biopsy for prostate cancer. Urology 2000;55:892-898.
20. Yaman O, Göǧüs C, Tulunay O, Tokatli Z, Ozden E: Increased prostate-specific antigen in subclinical prostatitis: the role of aggressiveness and extension of inflammation. Urol Int 2003;71:160-164.
21. Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E, Lee SE, Lee C: Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003;62:854-859.
22. Carver BS, Bozeman CB, Williams BJ, Venable DD: The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003;169:589-591.
23. Simardi LH, Tobias-Machado M, Kappaz GT, Taschner Goldenstein P, Potts JM, Wroclawski ER: Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study. Urology 2004;64:1098-1101.
24. Gümüs BH, Nese N, Gündüz MI, Kandiloglu AR, Ceylan Y, Büyüksu C: Does asymptomatic inflammation increase PSA? A histopathological study comparing benign and malignant tissue biopsy specimens. Int Urol Nephrol 2004;36:549-553.
25. Potts JM: Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000;164:1550-1553.
26. Karazanashvili G, Managadze L: Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination. Eur Urol 2001;39:538-543.
27. Lorente JA, Arango O, Bielsa O, Cortadellas R, Gelabert-Mas A: Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers 2002;17:84-89.
28. Bozeman CB, Carver BS, Eastham JA, Venable DD: Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002;167:1723-1726.
29. Guercio S, Terrone C, Tarabuzzi R, Poggio M, Cracco C, Bollito E, Scarpa RM: PSA decrease after levofloxacin therapy in patients with histological prostatitis. Arch Ital Urol Androl 2004;76:154-158.
30. Erol H, Beder N, Caliskan T, Dündar M, Unsal A, Culhaci N: Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies? Urol Int 2006;76:20-26.
31. Ornstein DK, Smith DS, Rao GS, Basler JW, Ratliff TL, Catalona WJ: Biological variation of total, free and percent free serum prostate specific antigen levels in screening volunteers. J Urol 1997;157:2179-2182.
32. Morote J, Raventós CX, Lorente JA, Enbabo G, López M, de Torres I: Intraindividual variations of total and percent free serum prostatic-specific antigen levels in patients with normal digital rectal examination. Eur Urol 1999;36:111-115.
33. Bunting PS, DeBoer G, Choo R, Danjoux C, Klotz L, Fleshner N: Intraindividual variation of PSA, free PSA and complexed PSA in a cohort of patients with prostate cancer managed with watchful observation. Clin Biochem 2002;35:471-475.
34. Kobayashi M, Kurokawa S, Tokue A: Intra-individual variation in total and percent free prostate-specific antigen levels in prostate cancer suspects. Urol Int 2005;74:198-202.
35. Bruun L, Becker C, Hugosson J, Lilja H, Christensson A: Assessment of intra-individual variation in prostate-specific antigen levels in a biennial randomized prostate cancer screening program in Sweden. Prostate 2005;65:216-221.
36. Nickel JC: The pre and post massage test (PPMT): a simple screen for prostatitis. Tech Urol 1997;3:38-43.
37. Söletormos G, Semjonow A, Sibley PE, Lamerz R, Petersen PH, Albrecht W, Bialk P, Gion M, Junker F, Schmid HP, Van Poppel H: Biological variation of total prostate-specific antigen: a survey of published estimates and consequences for clinical practice. Clin Chem 2005;51:1342-1351.
38. Nickel JC, True LD, Krieger JN, Berger RE, Boag AH, Young ID: Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int 2001;87:797-805.